As mentioned above, the two main identified proteases for the degradation of GLP-1 in vivo are DPP-4 and NEP-24.11
Healthcare providers considering clinical use of these peptides must ensure compliance with applicable federal, state, and local regulations
Its also generally not recommended during pregnancy or breastfeeding, or for anyone with a history of pancreatitis, severe gastrointestinal disease, or a known allergy to tirzepatide or any of its components
While not yet definitive predictors, such patterns warrant further investigation and may support future strategies incorporating hormonal surveillance, anatomical assessment, and timely pharmacologic adjuncts (e.g., GLP-1 receptor agonists) to optimize surgical outcomes
Our team put together this table to break down the core differences in a straightforward way
Tuy nhin, mt s trng hp c th gp cc tc dng ph nh|: Bn nn gp bc s t vn s dng, chnh liu hay ngng thuc nu gp phi cc tc dng ph trn